Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
GLP-1s arent just targeting the brain, like many older medications, said Carolina Haass-Koffler , associate professor of psychiatry, human behavior and of behavioral and social sciences at Brown
Hashimoto's isn't a big deal
These findings further underscore the notion that GLP-1R plays pivotal roles in both diseases
If patients are needing to go to a qualified medical practitioner to access the PBS-reduced medication costs, then theres an opportunity there for that prescriber to really help the individual with wraparound multidisciplinary care, so that they are getting best practice care and not just a script and off you go, which I think could actually make an individuals health worse in the long term. A spokesperson for the TGA said there are no medicines specifically for the treatment of overweight or obesity currently being considered for listing on the PBS by the Pharmaceutical Benefits Advisory Committee (PBAC)
